Updated Date:
10 Sep 2026
Product Detail:
OVIDREL choriogonadotropin alfa (rch) 250 microgram/ 0.5mL solution for injection pre-filled pen
Shortage Status:
Current
AUST R:
170446
Availability:
Limited Availability
Active Ingredient:
Choriogonadotropin alfa
Reason:
Unexpected increase in demand due to other sponsors unable to supply
Dosage Form:
Injection,solution
Supply Impact Dates
From 01 Jul 2024
To 31 Dec 2031
Management Action:
The sponsor is closely controlling the supply. An overseas-registered product has been approved for supply under section 19A. The approval holder, Merck Healthcare Pty Ltd, can be contacted for details on supply on 1800 633 463.